Refile: BUZZ-Sandoz rises after strong 2026 outlook

Sandoz AG

25/02/2026 08:49

Refiles to add company's Reuters Instrument Code (RIC), no changes to text

** Shares in Sandoz SDZ.S rise 6% after Swiss generic drugmaker posted better-than-expected 2026 outlook

** The company anticipates for 2026 sales growth of mid-to-high single digit and core EBITDA margin growth of around 100 bps

** "2025 was a good year for Sandoz and 2026 should also be," Vontobel says

** "Overall, we expect the solid results and implied 2pp Consensus upgrades to be well received," J.P. Morgan says

** 2025 results came in as expected, Zuercher Kantonalbank says, adding it considers 2026 guidance "as positive"

** Stock is on track for best day since August 2025, if gains hold

 (Reporting by Anastasiia Kozlova)

 ((Anastasiia.Kozlova@thomsonreuters.com))